Alzamend Neuro, Inc.盘中异动早盘股价大跌5.48%报3.62美元

市场透视2025-06-02

北京时间2025年06月02日22时00分，Alzamend Neuro, Inc.（ALZN.us）股票出现异动，股价急速跳水5.48%。截至发稿，该股报3.62美元/股，成交量17.6074万股，换手率21.98%，振幅6.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.04百万美元，每股收益-1.70美元，毛利-12685.00美元，市盈率-0.00倍。机构评级方面，在...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2540799546?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-06-02 22:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2540799546","market":"us","top_or_hot":-1,"title":"Alzamend Neuro, Inc.盘中异动 早盘股价大跌5.48%报3.62美元","media":"市场透视","content":"<div>\n<p>北京时间2025年06月02日22时00分，Alzamend Neuro, Inc.（ALZN.us）股票出现异动，股价急速跳水5.48%。截至发稿，该股报3.62美元/股，成交量17.6074万股，换手率21.98%，振幅6.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.04百万美元，每股收益-1.70美元，毛利-12685.00美元，市盈率-0.00倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220014950b9a25&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alzamend Neuro, Inc.盘中异动 早盘股价大跌5.48%报3.62美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlzamend Neuro, Inc.盘中异动 早盘股价大跌5.48%报3.62美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-06-02 22:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220014950b9a25&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年06月02日22时00分，Alzamend Neuro, Inc.（ALZN.us）股票出现异动，股价急速跳水5.48%。截至发稿，该股报3.62美元/股，成交量17.6074万股，换手率21.98%，振幅6.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.04百万美元，每股收益-1.70美元，毛利-12685.00美元，市盈率-0.00倍。机构评级方面，在...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220014950b9a25&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220014950b9a25&s=b","article_id":"2540799546","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602220014950b9a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2540799546","pubTimestamp":1748872813,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年06月02日22时00分，Alzamend Neuro, Inc.股票出现异动，股价急速跳水5.48%。截至发稿，该股报3.62美元/股，成交量17.6074万股，换手率21.98%，振幅6.84%。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Nutriband Inc C/Wts 涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1232.89%、847.16%、286.75%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为213.39%、87.92%、64.13%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BK4539":"次新股","ALZN":"Alzamend Neuro, Inc"},"translate_title":"Alzamend Neuro, Inc. shares fell 5.48% to $3.62 in early trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALZN":1},"content_text":"北京时间2025年06月02日22时00分，Alzamend Neuro, Inc.（ALZN.us）股票出现异动，股价急速跳水5.48%。截至发稿，该股报3.62美元/股，成交量17.6074万股，换手率21.98%，振幅6.84%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.04百万美元，每股收益-1.70美元，毛利-12685.00美元，市盈率-0.00倍。机构评级方面，在所有2家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Alzamend Neuro, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Lyra Therapeutics, Inc.、Oragenics Inc.、Nutriband Inc C/Wts (To Pur Com)涨幅较大，Lyra Therapeutics, Inc.、Oragenics Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1232.89%、847.16%、286.75%，振幅较大的相关个股有Lyra Therapeutics, Inc.、Oragenics Inc.、Immatics N V C/Wts 01/07/2025 (To Pur Com)，振幅分别为213.39%、87.92%、64.13%。Alzamend Neuro, Inc.公司简介：Alzamend Neuro Inc是一家早期临床阶段的生物制药公司。它专注于开发用于治疗神经退行性疾病和包括阿尔茨海默氏症在内的精神疾病的新产品。它的使命是开发和销售安全有效的治疗方法。该公司的产品线包括两种新型的治疗性候选药物AL001——一种专利离子共晶体技术，通过锂、脯氨酸和水杨酸盐的治疗性组合来传递锂，AL002是一种使用突变肽致敏细胞作为基于细胞的治疗性疫苗的专利方法，寻求恢复患者免疫系统的能力，以对抗阿尔茨海默氏症。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2540799546","isCrawlerRequest":true}

Alzamend Neuro, Inc.盘中异动 早盘股价大跌5.48%报3.62美元

精彩评论

Alzamend Neuro, Inc.盘中异动早盘股价大跌5.48%报3.62美元